571 studies were found. Here are studies 1 to 50.

1.		Recruiting	"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased Risk Condition: Prostate Cancer
2.		Recruiting	17-DMAG in Treating Patients With Metastatic or Unresectable Solid Tumors Condition: Cancer
3.		Recruiting	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Metastatic Kidney Cancer Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma
4.		Not yet recruiting	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity Cancer Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer
5.		Recruiting	17-N-Allylamino-17-Demethoxygeldanamycin in Treating Patients With Von Hippel-Lindau Disease and Kidney Cancer Conditions: stage I renal cell cancer; von Hippel-Lindau Syndrome
6.		Recruiting	17AAG to Treat Kidney Tumors in von Hippel-Lindau Disease Conditions: Hippel-Lindau Disease; Kidney Cancer
7.		Recruiting	A 20-week study of a new treatment for men with Benign Prostatic Hyperplasia (BPH). Condition: Prostatic Hyperplasia
8.		Not yet recruiting	3-AP and Cisplatin in Treating Patients With Recurrent or Persistent Platinum-Resistant Ovarian Epithelial or Primary Peritoneal Cancer Conditions: recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
9.		Recruiting	3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma Conditions: recurrent renal cell cancer; stage III renal cell cancer; Stage IV Renal Cell Cancer
10.		Recruiting	ABT-751 in Treating Young Patients With Refractory Solid Tumors Condition: childhood cancer
11.		Recruiting	Active Immunotherapy Of Metastatic Renal Cell Carcinoma Using Autologous Dendritic Cells Transfected With Autologous Total Tumor RNA Condition: Renal Cell Carcinoma
12.		Not yet recruiting	Acupuncture for Women's Health Conditions Conditions: Ovarian Neoplasms; Endometriosis; Pelvic Pain; Uterine Neoplasms
13.		Recruiting	Acupuncture in Treating Mucositis-Related Pain Caused by Chemotherapy in Patients Undergoing Stem Cell Transplantation Conditions: Cancer; oral complications of cancer and cancer therapy; Pain
14.		Recruiting	Adjuvant Intraperitoneal Carboplatin With Paclitaxel in Treating Patients Who Had Initial Debulking Surgery for Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube Cancer Conditions: Fallopian Tube Cancer; ovarian epithelial cancer; peritoneal cavity cancer
15.		Recruiting	Adjuvant Radiation Therapy Plus Hormone Therapy Compared With Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer Conditions: stage III prostate cancer; stage II prostate cancer
16.		Recruiting	Advanced Renal Cell Carcinoma Conditions: Carcinoma, Renal Cell; Kidney Neoplasms
17.		Recruiting	AG-013736 as Second-Line Therapy in Treating Patients With Metastatic Renal Cell (Kidney) Cancer Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer
18.		Recruiting	Allogeneic Stem Cell Transplantation in Treating Patients With Metastatic Renal Cell Cancer Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer
19.		Recruiting	AMG 162 in the Treatment of Bone Loss in Subjects Undergoing Androgen-Deprivation Therapy for Non-metastatic Prostate Cancer Condition: Prostate Cancer
20.		Recruiting	Amifostine in Treating Peripheral Neuropathy Caused by Paclitaxel in Patients With Solid Tumors Conditions: adult solid tumor; Breast Cancer; Lung Cancer; neurotoxicity; ovarian epithelial cancer; Prostate Cancer
21.		Recruiting	Amifostine in Treating Peripheral Neuropathy in Patients Who Have Received Chemotherapy for Gynecologic Malignancy Conditions: Endocrine Cancer; female reproductive cancer; neurotoxicity
22.		Recruiting	Amifostine to Protect the Rectum during External Beam Radiotherapy for Prostate Cancer Condition: Prostatic Neoplasms
23.		Recruiting	Androgen Suppression Plus Radiation Therapy in Treating Patients With Prostate Cancer Conditions: adenocarcinoma of the prostate; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer
24.		Recruiting	Angiotensin II Blockade Conditions: Kidney Disease; Proteinuria
25.		Recruiting	Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer Conditions: adenocarcinoma of the prostate; stage III prostate cancer; stage IV prostate cancer; recurrent prostate cancer
26.		Recruiting	APC8015 (Provenge®) in Treating Patients With Asymptomatic Metastatic Androgen-Independent Prostate Cancer Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
27.		Recruiting	APC8015F in Treating Patients With Progressive Metastatic Prostate Cancer and Disease-Related Pain Conditions: adenocarcinoma of the prostate; recurrent prostate cancer; stage IV prostate cancer
28.		Recruiting	Arsenic Trioxide in Treating Men With Germ Cell Cancer Conditions: recurrent testicular cancer; extragonadal germ cell tumor
29.		Recruiting	Arsenic Trioxide in Treating Patients With Advanced Neuroblastoma or Other Childhood Solid Tumors Condition: childhood cancer
30.		Recruiting	Assessing Quality of Life of Patients With Prostate Cancer Conditions: Quality of Life; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; stage IV prostate cancer
31.		Recruiting	Assessing Women's Attitudes About the Risk of Infertility Related to Adjuvant Therapy for Early Breast Cancer Conditions: sexual dysfunction and infertility; sexuality and reproductive issues; psychosocial effects/treatment; stage I breast cancer; stage II breast cancer
32.		Recruiting	Atrasentan in Treating Patients With Hormone-Naive Prostate Cancer Conditions: recurrent prostate cancer; stage I prostate cancer; stage II prostate cancer; stage III prostate cancer; adenocarcinoma of the prostate
33.		Recruiting	Atrasentan in Treating Patients With Locally Recurrent or Metastatic Kidney Cancer Conditions: Stage IV Renal Cell Cancer; recurrent renal cell cancer
34.		Recruiting	Avastin With or Without Erlotinib for Treatment of Metastatic Renal Cell Carcinoma Condition: Renal Cell Cancer
35.		Recruiting	BCG With or Without Mitomycin in Treating Patients With Bladder Cancer Conditions: stage 0 bladder cancer; recurrent bladder cancer; transitional cell carcinoma of the bladder
36.		Recruiting	Behavior Enhances Drug Reduction of Incontinence (BE-DRI) Condition: Urinary Incontinence
37.		Recruiting	Beneficial Effects of Antenatal Magnesium Sulfate (BEAM Trial) Conditions: Cerebral Palsy; Intraventricular hemorrhage; Periventricular Leukomalacia; Pulmonary Edema; Abruptio Placentae
38.		Recruiting	Benign Prostatic Hyperplasia Trial With Avodart And Tamsulosin Combination Treatment Condition: Benign Prostatic Hyperplasia
39.		Recruiting	Bevacizumab and Low-Dose Cyclophosphamide in Treating Patients With Recurrent Ovarian Epithelial or Primary Peritoneal Cancer Conditions: recurrent ovarian epithelial cancer; stage IV ovarian epithelial cancer; peritoneal cavity cancer
40.		Recruiting	Bevacizumab in Treating Patients With Persistent or Recurrent Cancer of the Cervix Conditions: recurrent cervical cancer; cervical squamous cell carcinoma
41.		Recruiting	Bevacizumab With or Without Erlotinib in Treating Patients With Metastatic Kidney Cancer Conditions: recurrent renal cell cancer; Stage IV Renal Cell Cancer; renal clear cell carcinoma
42.		Recruiting	Biological Therapy and Chemotherapy in Treating Patients With Metastatic Kidney Cancer or Colorectal Cancer Conditions: stage IV colon cancer; Stage IV rectal cancer; recurrent colon cancer; recurrent rectal cancer; Stage IV Renal Cell Cancer; ...
43.		Recruiting	Bladder Cancer Case Control Study of Arsenic in Water Condition: Bladder Cancer
44.		Recruiting	BMS 247550 to Treat Kidney Cancer Condition: Renal Cell Carcinoma
45.		Recruiting	Bortezomib and Mitoxantrone in Treating Patients With Advanced or Metastatic Androgen-Independent Prostate Cancer Conditions: recurrent prostate cancer; stage III prostate cancer; stage IV prostate cancer
46.		Recruiting	Bortezomib in Treating Patients With Advanced or Metastatic Transitional Cell Cancer of the Bladder, Renal Pelvis, or Ureter Conditions: recurrent bladder cancer; stage IV bladder cancer; metastatic transitional cell cancer of the renal pelvis and ureter; ...
47.		Recruiting	Bortezomib in Treating Patients With Advanced Transitional Cell Carcinoma of the Urothelium Conditions: Bladder Cancer; transitional cell cancer of the renal pelvis and ureter; Urethral Cancer
48.		Recruiting	Bortezomib in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer Conditions: recurrent ovarian epithelial cancer; peritoneal cavity cancer
49.		Recruiting	Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Children Conditions: Autoimmune Disease; Congenital Adrenal Hyperplasia; Healthy; Mental Disorder Diagnosed in Childhood; Neurologic Manifestations
50.		Recruiting	Breast Imaging Studies in Women at High Genetic Risk of Breast Cancer: Menstrual Cycle Study Conditions: Breast Cancer; Healthy; Ovarian Cancer